Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial

As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (12vPHiD-CV) was assessed in toddlers. 12vPHiD-CV contains CRM(197)-conjugated capsular polysaccharides of sero...

Descripción completa

Detalles Bibliográficos
Autores principales: Horn, Michael, Behre, Ulrich, Traskine, Magali, Dobbelaere, Kurt, Borys, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078718/
https://www.ncbi.nlm.nih.gov/pubmed/33175600
http://dx.doi.org/10.1080/21645515.2020.1810493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078718/
https://www.ncbi.nlm.nih.gov/pubmed/33175600
http://dx.doi.org/10.1080/21645515.2020.1810493

Ejemplares similares